secwatch.observer — SEC 8-K summary
======================================

Issuer:     Valion Bio, Inc. (VBIO)
CIK:        0001787740
Form:       8-K
Filed at:   2024-01-26T23:59:59+00:00
Accession:  0000950170-24-007968
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.02, 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Tivic Health Systems terminates COO Ryan Sabia, effective Jan 22, 2024
----------------------------------------------------------------------

- Ryan Sabia terminated as Chief Operating Officer effective immediately; no replacement named.
- Termination not related to company financial results or any disagreements on reporting practices.
- Sabia receives no severance; only earned salary and benefits through termination date.
- Sabia Employment Agreement (April 1, 2022) terminated concurrently.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1787740/000095017024007968/0000950170-24-007968-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1787740/000095017024007968/tivc-20240122.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-007968

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer